Photochemical & Photobiological Sciences
Paper
0.65 g; 14.9 mmol) in dry THF (5 mL). When effervescence of compound was collected as a colorless oil (0.038 g; 83% yield)
hydrogen had ceased (30 min), 5-chloro-1-phenyl-1H-tetrazole and identified as 4-methyl-4-(4-methylpent-3-enyl)-1-phenyl-
(2.5 g; 13.9 mmol) in dry THF (20 mL) was added and the final 3,4-dihydropyrimidin-2(1H)-one, 10a. IR νmax: 2973, 2870,
mixture was stirred at room temperature for about 3 h. Work- 1669, 1592, 1262 cm−1 1H-NMR (400 MHz, CD3OD): δ 1.26
;
up and crystallization of the crude from ethanol gave the (3H, s); 1.41 (3H, s); 1.57 (3H, s); 1.75–1.86 (2H, m); 2.01–2.39
5-(cyclohex-2-enyloxy)-1-phenyl-1H-tetrazole as white crystals (2H, m); 4.06–4.12 (1H, m); 5.06 (1H, d, J = 10.5 Hz); 5.23 (1H,
(2.1 g; 61% yield), mp 60–62 °C. IR νmax: 2927, 1591, 1549, d, J = 4.9 Hz); 6.88–6.92 (3H, m); 7.15 (2H, t, J = 7.8 Hz); 13C
1504, 1457, 910 cm−1; 1H NMR (400 MHz, CD3OD): δ 1.66–1.83 NMR (100 MHz, CD3OD): δC 23.40, 23.77, 24.78, 25.95, 43.71,
(2H, m, –CH2–), 2.04–2.18 (4H, m, –CH2–), 5.47–5.48 (1H, m, 51.21, 63.72, 71.06, 112.36, 123.58, 127.96, 128.51, 142.79,
CH–O–), 5.98, 6.00 (1H, d, –CHv), 6.09–6.13 (1H, m,vCH–), 148.06, 151.54; MS (EI), m/z 270 [M]+.
7.47–7.51 (1H, t, ArH), 7.54–7.58 (2H, t, ArH), 7.70–7.72 (2H, d,
ArH); 13C NMR (100 MHz, CD3OD): δC 18.06, 24.64, 27.87,
Similarly, the other compounds were prepared and isolated.
4.5.2. 1-Phenyl-3a,4,5,6-tetrahydro-1H-benzoimidazol-2(3H)-
78.52, 121.85, 123.44, 128.98, 129.44, 133.47, 134.91, 159.85; one (10b). 4-(Cyclohex-2-enyl)-1-phenyl-1H-tetrazol-5(4H)-one
MS (EI), m/z 242 [M]+.
4b (0.05 g; 0.20 mmol), irradiated for 15 min, gave a brown
4.4.4. 4-(Cyclohex-2-enyl)-1-phenyl-1H-tetrazol-5(4H)-one solid (0.025 g; 56% yield). IR νmax: 3327, 3063, 2937, 2867,
(4b). A neat sample of 5-(cyclohex-2-enyloxy)-1-phenyl-1H- 1690, 1548 cm−1; 1H-NMR (400 MHz, CD3OD): δ 0.90–0.95 (1H,
tetrazole (1.0 g; 4.1 mmol) was heated at 40 °C for 2 h to give m); 1.27–1.32 (5H, m); 3.34–3.38 (1H, t); 5.09(1H, m); 6.99–7.02
1-(cyclohex-2-enyl)-4-phenyl-1H-tetrazol-5(4H)-one as a yellow (1H, t, ArH); 7.25–7.29 (2H, t, ArH); 7.40–7.42 (2H, d, ArH); MS
oil (quantitative yield). IR νmax: 2927, 1724, 1595, 1552, 1504, (EI), m/z 214 [M]+.
1
1459, 904 cm–1; H NMR (400 MHz, CD3OD): δ 1.71–2.23 (6H,
4.5.3. 3-(1-Methylcyclohex-2-enyl)-benzoimidazol-2(1H)-one
m, –CH2–), 4.88–4.91 (1H, m, CH–N), 5.71–5.74 (1H, d, –CHv), (11). 4-(3-Methylcyclohex-2-enyl)-1-phenyl-1H-tetrazol-5(4H)-one
6.08–6.10 (1H, mvCH–), 7.39–7.42 (1H, t, ArH), 7.50–7.54 (2H, 4c (0.05 g; 0.19 mmol) was irradiated for 20 min. Isolation
t, ArH), 7.87–7.89 (2H, d, ArH); 13C NMR (100 MHz, CDCl3): δC afforded a yellow powder (0.034 g; 76% yield). IR νmax: 3124,
20.14, 24.78, 28.70, 52.03, 77.14, 77.45, 77.77, 119.71, 124.31, 3006, 2921, 1687, 1475, 1360 cm−1
;
1H-NMR (400 MHz,
127.98, 129.73, 133.45, 135.19; MS (EI), m/z 243 [M + H]+.
CD3OD): δ 1.52–1.75 (4H, m); 1.83 (3H, s); 2.11–2.15 (2H, m);
4.4.5. 4-(3-Methylcyclohex-2-enyl)-1-phenyl-1H-tetrazol-5- 6.02 (1H, dt, J = 10.1 Hz, J = 3.5 Hz); 6.09 (1H, d, J = 10.1 Hz);
(4H)-one (4c). 3-Methyl-cyclohex-2-enol (0.62 g; 5.54 mmol) in 6.91–7.01 (3H, m); 7.60 (1H, d, J = 8.0 Hz); 13C NMR (100 MHz,
dry THF (30 mL) was added to a slurry of sodium hydride CD3OD): δC 18.78, 24.58, 26.55, 33.18, 58.31, 108.56, 112.08,
(55% in mineral oil; 0.32 g; 7.4 mmol) in dry THF (5 mL). 120.16, 120.68, 128.55, 129.12, 130.92, 132.72, 155.47; MS (EI),
When effervescence (hydrogen) had ceased (20 min) 5-chloro- m/z 228 [M]+.
1-phenyl-1H-tetrazole (1.0 g; 5.54 mmol) in dry THF (10 mL)
was added, and the mixture was stirred at ≈10 °C for 4 h.
4-(3-Methylcyclohex-2-enyl)-1-phenyl-1H-tetrazol-5(4H)-one was
obtained as a light yellow oil (1.1 g; 71% yield), indicating that
Acknowledgements
the synthesised ether readily isomerises to the corresponding The authors acknowledge Fundação para a Ciência e Tecnolo-
tetrazolone 4c. IR νmax: 2927, 1721, 1596, 1504, 1460, 1367, gia (FCT) and FEDER [Projects PTDC/QUI/67674/2006 and
1095, 904 cm−1 1H NMR (400 MHz, CD3OD): δ 1.69 (3H, s, PTDC/QUI/71203/2006] for financial support.
;
CH3), 1.79–1.86 (4H, m, –CH2CH2–), 2.09–2.11 (2H, m, CH2),
5.97–6.03 (2H, m, CHvCH), 7.38–7.42 (1H, t, ArH), 7.50–7.54
(2H, t, ArH), 7.85–7.87 (2H, d, ArH); 13C NMR (100 MHz,
CD3OD): δC 18.34, 24.21, 25.29, 32.78, 60.16, 119.63, 127.59,
128.15, 129.05, 130.50, 134.59, 148.71; MS (EI), m/z 257
[M + H]+.
References
1 S. C. S. Bugalho, E. M. S. Macoas, M. L. S. Cristiano and
R. Fausto, Low temperature matrix-isolation and solid state
vibrational spectra of tetrazole, Phys. Chem. Chem. Phys.,
2001, 3, 3541–3547.
2 Y. Tamura, F. Watanabe, T. Nakatani, K. Yasui, M. Fuji,
T. Komurasaki, H. Tsuzuki, R. Maekawa, T. Yoshioka,
K. Kawada, K. Sugita and M. Ohtani, Highly selective and
orally active inhibitors of type IV collagenase (MMP-9 and
MMP-2): N-sulfonylamino acid derivatives, J. Med. Chem.,
1998, 41, 640–649.
3 G. Maier, J. Eckwert, A. Bothur, H. P. Reisenauer and
C. Schmidt, Photochemical fragmentation of unsubstituted
tetrazole, 1,2,3-triazole, and 1,2,4-triazole: first matrix-
spectroscopic identification of nitrilimine HCNNH, Liebigs
Ann., 1996, 1041–1053.
4.5. Preparation of compounds 10a,b and 11 (preparative
scale irradiations)
4.5.1. 4-Methyl-4-(4-methylpent-3-enyl)-1-phenyl-3,4-dihydro-
pyrimidin-2(1H)-one (10a). 1-(3,7-Dimethylocta-1,6-dien-3-yl)-4-
phenyl-1H-tetrazol-5(4H)-one 4a (0.05 g; 0.17 mmol) in metha-
nol (75 ml) was irradiated at λ = 254 nm with continuous stir-
ring, with the cell at a distance of 10 cm from a 16 W low
pressure Hg lamp until no starting material was detected by
GC-MS analysis (40 min). The final solution was removed, the
solvent was evaporated and the major photoproduct was iso-
lated by column chromatography on silica gel, using a mixture
of hexane and ethyl acetate as an eluent. The isolated
This journal is © The Royal Society of Chemistry and Owner Societies 2013
Photochem. Photobiol. Sci., 2013, 12, 272–283 | 281